Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Antoine Dutertre

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nature Immunology|February 13, 2024
A new step in understanding mouse cDC ontogenyCharles-Antoine Dutertre
Medecine Sciences : M/S|November 5, 2020
[Identification of circulating inflammatory dendritic cells by a multi-omic approach]Charles-Antoine Dutertre, Florent Ginhoux
Journal De La Societe De Biologie|July 27, 2007
[Monoclonal antibodies, act two: new molecules for new challenges]Charles-Antoine Dutertre, Jean-Luc Teillaud
Medecine Sciences : M/S|December 29, 2009
[Antibodies: better knowledge for a better use]Riad Abès, Charles-Antoine Dutertre, Jean-Luc Teillaud
Cellular Immunology|September 29, 2014
Aligning bona fide dendritic cell populations across speciesCharles-Antoine Dutertre, Lin-Fa Wang, Florent Ginhoux
Immunity|March 9, 2022
Single-cell immunology: Past, present, and futureFlorent Ginhoux, Adam Yalin, Charles Antoine Dutertre, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activating and inhibitory Fcgamma receptors in immunotherapy: being the actor or being the targetRiad Abès, Charles-Antoine Dutertre, Lauren Agnelli, et al.
Nature Reviews. Immunology|September 10, 2020
Genetic models of human and mouse dendritic cell development and functionDavid A Anderson, Charles-Antoine Dutertre, Florent Ginhoux, et al.
Critical Reviews in Oncology/Hematology|January 24, 2007
FcgammaR: The key to optimize therapeutic antibodies?Sophie Sibéril, Charles-Antoine Dutertre, Wolf-Herman Fridman, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nature Immunology|February 13, 2024
A new step in understanding mouse cDC ontogenyCharles-Antoine Dutertre
Medecine Sciences : M/S|November 5, 2020
[Identification of circulating inflammatory dendritic cells by a multi-omic approach]Charles-Antoine Dutertre, Florent Ginhoux
Journal De La Societe De Biologie|July 27, 2007
[Monoclonal antibodies, act two: new molecules for new challenges]Charles-Antoine Dutertre, Jean-Luc Teillaud
Medecine Sciences : M/S|December 29, 2009
[Antibodies: better knowledge for a better use]Riad Abès, Charles-Antoine Dutertre, Jean-Luc Teillaud
Cellular Immunology|September 29, 2014
Aligning bona fide dendritic cell populations across speciesCharles-Antoine Dutertre, Lin-Fa Wang, Florent Ginhoux
Immunity|March 9, 2022
Single-cell immunology: Past, present, and futureFlorent Ginhoux, Adam Yalin, Charles Antoine Dutertre, et al.
Expert Review of Clinical Immunology|May 19, 2010
Activating and inhibitory Fcgamma receptors in immunotherapy: being the actor or being the targetRiad Abès, Charles-Antoine Dutertre, Lauren Agnelli, et al.
Nature Reviews. Immunology|September 10, 2020
Genetic models of human and mouse dendritic cell development and functionDavid A Anderson, Charles-Antoine Dutertre, Florent Ginhoux, et al.
Critical Reviews in Oncology/Hematology|January 24, 2007
FcgammaR: The key to optimize therapeutic antibodies?Sophie Sibéril, Charles-Antoine Dutertre, Wolf-Herman Fridman, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Pageof 9